Market Research Logo

Parexel International Corporation (PRXL) - Financial and Strategic SWOT Analysis Review

Section 1 - About the Company
Parexel International Corporation - Key Facts
Parexel International Corporation - Key Employees
Parexel International Corporation - Key Employee Biographies
Parexel International Corporation - Major Products and Services
Parexel International Corporation - History
Parexel International Corporation - Company Statement
Parexel International Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Parexel International Corporation - Business Description
Parexel International Corporation - Corporate Strategy
Parexel International Corporation - SWOT Analysis
SWOT Analysis - Overview
Parexel International Corporation - Strengths
Parexel International Corporation - Weaknesses
Parexel International Corporation - Opportunities
Parexel International Corporation - Threats
Parexel International Corporation - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Parexel International Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Parexel International Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Parexel International Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
Parexel International Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016
Parexel International Corporation, Recent Deals Summary
Section 5 – Company’s Recent Developments
Oct 06, 2016: PAREXEL Launches Active Tracking Service for Monitoring and Managing Temperature-Controlled Investigational Medicinal Products
Sep 19, 2016: Christian Dreger Joins PAREXEL as Senior Vice President, PAREXEL Access and PAREXEL Consulting
Aug 03, 2016: PAREXEL International Reports Fourth Quarter and Fiscal Year 2016 Results
Aug 01, 2016: PAREXEL Appoints Four Executives to Senior Leadership Team
Jun 30, 2016: PAREXEL International Outlines Growth Strategy and Updates Financial Guidance at Investor Day
Jun 20, 2016: PAREXEL Experts to Discuss Key Drug Development Insights at DIA 2016
Jun 10, 2016: PAREXEL Announces Master Services Agreement with Pfizer
Apr 27, 2016: PAREXEL International Reports Third Quarter Fiscal Year 2016 Results
Apr 13, 2016: PAREXEL and EMC Form Alliance to Provide Cloud-Based Document and Regulatory Information Management Services
Feb 17, 2016: PAREXEL Launches Expanded Genomic Research Services
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Parexel International Corporation, Key Facts
Parexel International Corporation, Key Employees
Parexel International Corporation, Key Employee Biographies
Parexel International Corporation, Major Products and Services
Parexel International Corporation, History
Parexel International Corporation, Other Locations
Parexel International Corporation, Subsidiaries
Parexel International Corporation, Key Competitors
Parexel International Corporation, Ratios based on current share price
Parexel International Corporation, Annual Ratios
Parexel International Corporation, Interim Ratios
Parexel International Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Parexel International Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Parexel International Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
Parexel International Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016
Parexel International Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Parexel International Corporation, Performance Chart (2012 - 2016)
Parexel International Corporation, Ratio Charts
Parexel International Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Parexel International Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Parexel International Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
Parexel International Corporation, Medical Equipment, Deals by Type, 2010 to YTD 2016

Parexel International Corporation (PRXL) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Parexel International Corporation (Parexel) is a biopharmaceutical outsourcing services company which focuses on providing various services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of services including clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics/outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, clinical supply and drug logistics, post-marketing surveillance, regulatory and product development and commercialization consulting among several others. Parexel caters its products and services to pharmaceutical, biotechnology and medical device industries worldwide. The company offers its services through a network of offices in various countries across the world. Parexel is headquartered in Waltham, Massachusetts, the US.

Parexel International Corporation Key Recent Developments

Oct 06, 2016: PAREXEL Launches Active Tracking Service for Monitoring and Managing Temperature-Controlled Investigational Medicinal Products
Sep 19, 2016: Christian Dreger Joins PAREXEL as Senior Vice President, PAREXEL Access and PAREXEL Consulting
Aug 03, 2016: PAREXEL International Reports Fourth Quarter and Fiscal Year 2016 Results
Aug 01, 2016: PAREXEL Appoints Four Executives to Senior Leadership Team
Jun 30, 2016: PAREXEL International Outlines Growth Strategy and Updates Financial Guidance at Investor Day

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;